Serotonin and Noradrenaline Reuptake Inhibitors

All categories
DBCAT002715Therapeutic category

Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS. A DrugBank category of 7 drugs. 7 of them are approved.

Part of
Serotonin Modulators
Also known as
NRIs and SSRIs · Selective Serotonin and Noradrenaline Reuptake Inhibitors · Selective Serotonin and Norepinephrine-reuptake Inhibitors · Serotonin and Noradrenaline Uptake Inhibitors · Serotonin and Norepinephrine Reuptake Inhibitors
Drugs

What you can answer from here — as of August 12, 2019

7DrugsEach linked to its full drug card
Listed above
11Drug targetsEvery drug–target pair in the class, with bond type
Sign in
4,284Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Serotonin and Noradrenaline Reuptake Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In